These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33432347)

  • 1. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
    Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY; Jian YK; Zhu HY; Li B
    Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
    Yang M; Zhang T; Zhang Y; Ma X; Han J; Zeng K; Jiang Y; Wang Z; Wang Z; Xu J; Hua Y; Cai Z; Sun W
    J Exp Clin Cancer Res; 2021 May; 40(1):166. PubMed ID: 33980265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.
    Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W
    J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
    Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
    Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy.
    Huang CY; Wei PL; Wang JW; Makondi PT; Huang MT; Chen HA; Chang YJ
    Dis Markers; 2019; 2019():4569718. PubMed ID: 30719181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
    Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
    Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
    Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways.
    Wang Y; Wang S; Liu J; Lu Y; Li D
    Chem Biol Interact; 2018 Jun; 290():44-51. PubMed ID: 29782821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.
    Wang Q; Cai J; Wang J; Xiong C; Zhao J
    Tumour Biol; 2014 Dec; 35(12):12743-8. PubMed ID: 25227664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy in osteosarcoma.
    O'Farrill JS; Gordon N
    Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sCLU as prognostic biomarker and therapeutic target in osteosarcoma.
    Ma J; Gao W; Gao J
    Bioengineered; 2019 Dec; 10(1):229-239. PubMed ID: 31117872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA
    Li H; Lan M; Liao X; Tang Z; Yang C
    Technol Cancer Res Treat; 2020; 19():1533033819898728. PubMed ID: 31960764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR.
    He M; Yan G; Wang Y; Gong R; Lei H; Yu S; He X; Li G; Du W; Ma T; Gao M; Yu M; Liu S; Xu Z; Idiiatullina E; Zagidullin N; Pavlov V; Cai B; Yuan Y; Yang L
    J Cell Mol Med; 2021 Jun; 25(11):4962-4973. PubMed ID: 33960631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.